The company strives to be a pioneer in providing patients with access to healthcare, particularly to generic and biosimilar medicinal products. To this end, it acquires, manages and disposes of participations and intellectual property in the healthcare and medical products industry and conducts all business, both domestically and abroad, that is directly or indirectly related to this purpose. The company may acquire, sell, encumber and manage participations in other companies, intellectual property rights and real estate, both domestically and abroad, as well as establish branches and subsidiaries, both domestically and abroad. In pursuing its corporate purpose, the company aims to become the world's leading and most respected company in the field of generic and biosimilar medicinal products.